Rituximab After Stem Cell Transplant Boosts Survival in Mantle Cell Lymphoma – Cancer Therapy Advisor
Rituximab After Stem Cell Transplant Boosts Survival in Mantle Cell LymphomaCancer Therapy AdvisorMaintenance rituximab (MR) after autologous stem cell transplant (ASCT) confers a benefit in progression-free survival in patients with mantle cell lympho… Continue reading
